Novartis AG
Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections

Last updated:

Abstract:

The invention provides compounds of Formula (I): ##STR00001## as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.

Status:
Application
Type:

Utility

Filling date:

13 Jul 2021

Issue date:

10 Feb 2022